HC Wainwright Increases Apellis Pharmaceuticals (NASDAQ:APLS) Price Target to $92.00
Apellis Pharmaceuticals (NASDAQ:APLS – Get Free Report) had its target price raised by analysts at HC Wainwright from $82.00 to $92.00 in a report issued on Wednesday, Benzinga reports. The brokerage presently has a “buy” rating on the stock. HC Wainwright’s target price would suggest a potential upside of 44.02% from the company’s previous close. […]
More Stories
Inspire Advisors LLC Decreases Position in AAON, Inc. (NASDAQ:AAON)
Inspire Advisors LLC reduced its holdings in shares of AAON, Inc. (NASDAQ:AAON – Free Report) by 4.5% in the 3rd...
Trust Point Inc. Sells 25 Shares of Chemed Co. (NYSE:CHE)
Trust Point Inc. cut its stake in shares of Chemed Co. (NYSE:CHE – Free Report) by 0.6% in the 3rd...
Trust Point Inc. Acquires 238 Shares of Walmart Inc. (NYSE:WMT)
Trust Point Inc. grew its stake in shares of Walmart Inc. (NYSE:WMT – Free Report) by 0.4% during the third...
Aaron Wealth Advisors LLC Acquires 4,790 Shares of ING Groep (NYSE:ING)
Aaron Wealth Advisors LLC boosted its holdings in shares of ING Groep (NYSE:ING – Free Report) by 6.9% during the...
Norfolk Southern Co. (NYSE:NSC) Shares Sold by Trust Co. of Vermont
Trust Co. of Vermont decreased its position in Norfolk Southern Co. (NYSE:NSC – Free Report) by 0.4% in the 3rd...
Danaher Co. (NYSE:DHR) Shares Sold by Trust Co. of Vermont
Trust Co. of Vermont trimmed its holdings in shares of Danaher Co. (NYSE:DHR – Free Report) by 0.3% in the...